Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant

Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1787-1790. doi: 10.1007/s00259-020-04742-w.

EANM Neuroimaging Committee:
Nathalie Albert, Ronald Boellaard, Diego Cecchin, Ozgul Ekmekcioglu, Eric Guedj, Ian Law, Ivan Penuelas, Franck Semah, Tatjana Traub-Weidinger, Elsmarieke van de Giessen, Andrea Varrone

¹ Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany. henryk.barthel@medizin.uni-leipzig.de.
² Department of Nuclear Medicine, University of Navarra Clinic, Pamplona, Spain.
³ Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁴ German Centre for Neurodegenerative Diseases, Bonn-Cologne, Germany.
⁵ Molecular Organization of the Brain, Research Centre Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
⁶ Division of Nuclear Medicine and Molecular Imaging, Geneva University, Geneva, Switzerland.
⁷ VUMC Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
⁸ Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

No abstract available

Publication types